Treatment Trials

2 Clinical Trials for Various Conditions

Focus your search

      COMPLETED
      International, Multicenter Study of a Twenty-eight Week, Open-label, Titrated Oral Lixivaptan Administration in Patients With Chronic Hyponatremia: Extension to Studies CK-LX3401, 3405, and 3430
      Description

      To evaluate the overall safety and continued efficacy of oral lixivaptan capsules in subjects with euvolemic and hypervolemic hyponatremia

      Conditions
      Hyponatremia With Normal Extracellular Fluid VolumeHyponatremia With Excess Extracellular Fluid Volume
      Talk to us
      COMPLETED
      Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Oral Lixivaptan Capsules in Subject With Euvolemic Hyponatremia
      Description

      The present study is designed to confirm and extend the observation from previous studies that lixivaptan therapy corrects hyponatremia, in euvolemic subject, including subjects with SIADH.

      Conditions
      Hyponatremia With Normal Extracellular Fluid Volume
      Talk to us